DSS, INC. sold 156 shares of IMPACT BIOMEDICAL INC. at $7.06 for −$1.10k on Sep 24, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
10% owner
10%
Filed Sep 24, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$1,101.16Shares × reported price
Shares traded
156Common Stock
Price per share
$7.06Reported price. Read footnotes for ranges.
% of reported position traded
0.03%This security and ownership context
Holdings after
589,518Direct
Trade date
Sep 24, 2026Sell
Filed
Sep 24, 2026, 7:37 PM ET0-day reporting delay
Accession
0001493152-26-044207Code S · Transaction 229366
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 589,674 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 22, 2026Sell723$0.55−$397.65Trade 229364
Sep 23, 2026Sell27$6.95−$187.65Trade 229365
3 transaction rows in this filing. Joint filers share the same rows.

IBO price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IBO · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Oct 1, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.